Ecatx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ecatx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ecatx Today - Breaking & Trending Today

Perspective Therapeutics (NYSEAMERICAN:CATX) Sees Large Volume Increase

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) shares saw an uptick in trading volume on Thursday . 6,515,337 shares were traded during trading, an increase of 56% from the previous session’s volume of 4,163,777 shares.The stock last traded at 1.59 and had previously closed at 1.57. Wall Street Analysts Forecast Growth Several research firms […] ....

Lantheus Alpha Therapy Llc , Bleakley Financial Group , York Mellon Corp , Royal Bank , Simplicity Wealth , Advisory Group , Investment Counsel Inc , Perspective Therapeutics Inc , Cantor Fitzgerald , Perspective Therapeutics , Get Free Report , Lantheus Alpha Therapy , Financial Group , New York Mellon Corp , Perspective Therapeutics Daily , Nyseamerican Catx ,

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Director Purchases 16,170.24 in Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) Director Robert F. Williamson III bought 25,266 shares of the stock in a transaction dated Monday, January 29th. The stock was acquired at an average price of 0.64 per share, with a total value of 16,170.24. Following the completion of the purchase, the director now owns 211,555 […] ....

United States , Robertf Williamson , Perkins Capital Management Inc , Wealth Effects , Taylor Morgan Wealth Management , Perspective Therapeutics Inc , Perspective Therapeutics Company Profile , Vanguard Group Inc , Perspective Therapeutics , Get Free Report , Director Robert , Capital Management , Morgan Wealth Management , Creative Planning , Perspective Therapeutics Daily , Nyseamerican Catx , Insider Trading , Nsider Trades ,

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Insider Purchases 140,000.00 in Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) insider Markus Puhlmann acquired 280,000 shares of the stock in a transaction on Wednesday, January 24th. The shares were acquired at an average price of 0.50 per share, with a total value of 140,000.00. Following the purchase, the insider now owns 1,375,425 shares in the company, valued […] ....

United States , Markus Puhlmann , Perspective Therapeutics Inc , Wealth Effects , Charles Schwab Investment Management Inc , York Mellon Corp , Securities Exchange Commission , Taylor Morgan Wealth Management , Perspective Therapeutics Company Profile , Perspective Therapeutics , Get Free Report , Exchange Commission , Schwab Investment Management , New York Mellon Corp , Morgan Wealth Management , Perspective Therapeutics Daily , Nyseamerican Catx , Insider Trading , Nsider Trades ,

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Director Robert F. Williamson III Buys 22,134 Shares of Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) Director Robert F. Williamson III acquired 22,134 shares of the company’s stock in a transaction on Thursday, January 25th. The stock was purchased at an average cost of 0.49 per share, for a total transaction of 10,845.66. Following the completion of the transaction, the director now owns […] ....

United States , Robertf Williamson , York Mellon Corp , Perspective Therapeutics Inc , Charles Schwab Investment Management Inc , Taylor Morgan Wealth Management , Wealth Effects , Perspective Therapeutics Company Profile , Perspective Therapeutics , Get Free Report , Director Robert , Schwab Investment Management , New York Mellon Corp , Morgan Wealth Management , Perspective Therapeutics Daily , Nyseamerican Catx , Insider Trading , Nsider Trades ,

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Insider Markus Puhlmann Purchases 280,000 Shares of Stock

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) insider Markus Puhlmann bought 280,000 shares of the stock in a transaction dated Wednesday, January 24th. The stock was bought at an average price of 0.50 per share, with a total value of 140,000.00. Following the purchase, the insider now owns 1,375,425 shares of the company’s stock, […] ....

United States , Markus Puhlmann , Securities Exchange Commission , Taylor Morgan Wealth Management , Charles Schwab Investment Management Inc , York Mellon Corp , Perspective Therapeutics Inc , Wealth Effects , Perspective Therapeutics , Get Free Report , Exchange Commission , Schwab Investment Management , New York Mellon Corp , Morgan Wealth Management , Perspective Therapeutics Daily , Nyseamerican Catx , Insider Trading , Nsider Trades ,